Effects and limitations of pentoxifylline therapy in various stages of peripheral vascular disease of the lower extremity

The American Journal of Surgery

Volumn 160, Issue 3, 1990, Pages 266-270

  AbuRahma, Ali F ^a   Woodruff, Bradley A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PENTOXIFYLLINE;

ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL;

DIABETES MELLITUS; HUMAN; INTERMITTENT CLAUDICATION; LEG; LOCOMOTION; PENTOXIFYLLINE; SEVERITY OF ILLNESS INDEX; SMOKING; THEOBROMINE;

EID: 0025140721     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(06)80020-6     Document Type: Article

References (20)

1. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease in patients
2. Drug treatment of claudication vasodilators hemorrheologic agents and antiserotonin drugs
3. New prospects for the conservative management of peripheral arterial disease: clinical investigations with pentoxifylline (Trental, 400)
4. Beneficial hemorrheologic therapy of chronic peripheral arterial disorders with pentoxifylline: results of double-blind study versus vasodilator-nylidrin
5. Double-blind trial of pentoxifylline in diabetics with peripheral arterial disorders
6. Experiences with pentoxifylline in chronic obliterating disease of the leg arteries in clinic and practice
7. Influence of pentoxifylline (Trental 400) on microcirculation, poststenotic blood pressure and walking capacity in patients with chronic occlusive arterial disease
8. The measured effect of stopping smoking on intermittent claudication
9. Physical training of patients with intermittent claudication: indications, methods, and results
10. Perspective: intermittent claudication
11. Effects of physical training on different categories of patients with intermittent claudication
12. Failure of vasodilator drugs in arteriosclerosis obliterans
13. Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication
14. Hemorrheology and peripheral vascular diseases a new therapeutic approach
15. Behandlung von Arteriophalthien mit Trental 400; ergebnisse einer Doppelblid studie
16. Behandlung von Patienten mit arterieller Verschlusskrankheit (Stadium 11) mit pentoxifylline. Haemodynamische und ergometrische Befunde
17. Treatment of claudication with pentoxifylline: are benefits related to improvement in viscosity?
18. Determinants of response to pentoxifylline therapy in patients with intermittent claudication
19. The effects of pentoxifylline on patients with intermittent claudication
20. Failure of pentoxifylline for end-stage peripheral vascular disease